ACTIVE SUBSTANCE / INN

BUPRENORPHINE HYDROCHLORIDE

Brand name(s): BELBUCA, BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE, SUBUTEX, BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE, BUPRENEX, BUNAVAIL
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA205637
ANDA214737
ACTIVE SUBSTANCE
Buprenorphine Hydrochloride
REGULATORS
FDA
SPONSORS / MAH
ACTAVIS LABS UT INC, BDSI, AM REGENT
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BUPRENORPHINE HYDROCHLORIDEANDA078331AM REGENTDiscontinued
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA207000SPECGX LLCPrescription
BUPRENORPHINE HYDROCHLORIDEANDA090279RUBICON RESEARCHPrescription
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA091149TEVA PHARMS USADiscontinued
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDEANDA204383ACTAVIS LABS UT INCNone (Tentative Approval)
BUNAVAILNDA205637BDSIDiscontinued
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA214737SUN PHARM INDUSTRIESNone (Tentative Approval)
SUBUTEXNDA020732INDIVIORDiscontinued
BUPRENEXNDA018401INDIVIORDiscontinued
BELBUCANDA207932BDSIPrescription

FULL INTELLIGENCE ON BUPRENORPHINE HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →